SEC Contract Filing

Filing Date: 2025-05-02

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ef20048241_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
 <head>
 <title></title>
 <!-- Licensed to: Summit Financial
 Document created using Broadridge PROfile 25.3.2.5298
 Copyright 1995 - 2025 Broadridge -->
 </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
 <div>
 <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
 <div>
 <div style="text-align: center; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt;"><a name="z_Hlk167006739"></a></font></div>
 <div style="text-align: right; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;">Exhibit 10.1<br>
 </font></div>
 <div style="text-align: center; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
 </font></div>
 <div style="text-align: center; font-weight: bold;"><a name="z_Hlk167006739"></a>SECURITIES PURCHASE AGREEMENT</div>
 <div>&#160;</div>
 <div style="text-align: justify; text-indent: 36pt;">This Securities Purchase Agreement (this &#8220;<font style="font-weight: bold;">Agreement</font>&#8221;) is dated as of April 30, 2025, between PDS Biotechnology Corporation, a Delaware corporation (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), each buyer identified on the signature pages hereto (each, including its successors and assigns, a &#8220;<font style="font-weight: bold;">Buyer</font>&#8221; and collectively, the &#8220;<font style="font-weight: bold;">Buyers</font>&#8221;), and JGB Collateral LLC, a Delaware limited liability company, as Collateral Agent.</div>
 <div>&#160;</div>
 <div style="text-align: justify; text-indent: 36pt;">WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below) and Rule 506 promulgated thereunder, the Company
 desires to issue and sell to each Buyer, and each Buyer, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</div>
 <div>&#160;</div>
 <div style="text-align: justify; text-indent: 36pt;">NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the
 Company and each Buyer agree as follows:</div>
 <div>&#160;</div>
 <div style="text-align: center; font-weight: bold;">ARTICLE I.<br>
 DEFINITIONS</div>
 <div>&#160;</div>
 <div style="font-size: 12pt; text-indent: 36pt;"><font style="font-size: 10pt;">1.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Definitions</u> . In addition to the terms defined elsewhere in this Agreement: (a)&#160;capitalized terms that are not otherwise defined herein have the
 meanings given to such terms in the Debentures (as defined herein), and (b) the following terms have the meanings set forth in this Section 1.1:</font></div>
 <div>&#160;</div>
 <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">Action</font>&#8221; shall have the meaning assigned to such term in <u>Section 3.1(j)</u>.</div>
 <div>&#160;</div>
 <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">Affiliate</font>&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under
 common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</div>
 <div>&#160;</div>
 <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">Board of Directors</font>&#8221; means the board of directors of the Company.</div>
 <div>&#160;</div>
 <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">Business Day</font>&#8221; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or
 required by law to remain closed; <u>provided</u>, <u>however</u>, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#8220;stay at home&#8221;, &#8220;shelter-in-place&#8221;, &#8220;non-essential employee&#8221; or
 any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City
 of New York are generally open for use by customers on such day.</div>
 <div>&#160;</div>
 <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">Buyer Party</font>&#8221; shall have the meaning assigned to such term in <u>Section&#160;4.9</u>.<a name="z_Ref309990993"></a><a name="z_Ref309990992"></a></div>
 <div>&#160;</div>
 <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">Closing</font>&#8221; means the closing of the purchase and sale of the Debentures pursuant to <u>Section 2.1</u>.</div>
 <div>&#160;</div>
 <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
 <div class="BRPFPageBreak" style="page-break-after: always;">
 <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
 </div>
 <!--PROfilePageNumberReset%Num%2%%%-->
 <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">Closing Date</font>&#8221; means the Trading Day on which all of the Transaction Documents re